Literature DB >> 6341442

Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of regular doses of thyroxine and triiodothyronine.

B Busnardo, F Bui, M E Girelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341442     DOI: 10.1007/BF03350558

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  17 in total

1.  Bihormonal regulation of the thyrotropin-releasing hormone receptor in mouse pituitary thyrotropic tumor cells in culture.

Authors:  M C Gershengorn
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

2.  A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: effects of puromycin and cycloheximide.

Authors:  C Y Bowers; K L Lee; A V Schally
Journal:  Endocrinology       Date:  1968-01       Impact factor: 4.736

3.  Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy.

Authors:  A G Vagenakis; L E Braverman; F Azizi; G I Portinay; S H Ingbar
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

4.  Biphasic thyrotropin suppression in euthyroid and hypothyroid rats.

Authors:  M I Surks; B M Lifschitz
Journal:  Endocrinology       Date:  1977-09       Impact factor: 4.736

5.  Peripheral metabolism of homologous thyrotropin in euthyroid and hypothyroid rats: acute effects of thyrotropin-releasing hormone, triiodothyronine, and thyroxine.

Authors:  J E Silva; P R Larsen
Journal:  Endocrinology       Date:  1978-06       Impact factor: 4.736

6.  Suppression of the TSH response to TRH by thyroxine therapy in differentiated thyroid carcinoma patients.

Authors:  B A Lamberg; M Rantanen; P Saarinen; K Liewendahl; A Sivula
Journal:  Acta Endocrinol (Copenh)       Date:  1979-06

7.  TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma.

Authors:  B Busnardo; R Vagelista; M E Girelli; F Bui; C Lazzi
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

8.  Evidence against a major role of L-thyroxine at the pituitary level: studies in rats treated with iopanoic acid (telepaque).

Authors:  M J Obregon; A Pascual; J Mallol; G Morreale de Escobar; F Escobar del Rey
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

9.  Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.

Authors:  P R Larsen; T E Dick; B P Markovitz; M M Kaplan; T G Gard
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

10.  TSH synthesis and release in the thyroidectomized rat: b) effect of T3.

Authors:  O Spira; A Birkenfeld; A Avni; J Gross; A Gordon
Journal:  Acta Endocrinol (Copenh)       Date:  1979-11
View more
  2 in total

1.  Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of an optimal saturation regimen with thyroxine or triiodothyronine.

Authors:  B Busnardo; F Bui; M E Girelli
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 2.  Clinical use of sensitive assays for thyroid-stimulating hormone.

Authors:  P A Masters; R J Simons
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.